Metis Global Partners, LLC Pfizer Inc Transaction History

Metis Global Partners, LLC

$3.16 Billion
Q3 2024

A detailed history of Metis Global Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Metis Global Partners, LLC holds 317,965 shares of PFE stock, worth $8.5 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

317,965

Previous 311,963 1.92%

Holding current value

$8.5 Million

Previous $8.73 Million 5.42%

% of portfolio

0.29%

Previous 0.3%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$27.7 - $31.39 $166,255 - $188,402	6,002 Added 1.92%	317,965 $9.2 Million
Q2 2024 Aug 06, 2024	BUY	$25.26 - $29.6 $83,989 - $98,420	3,325 Added 1.08%	311,963 $8.73 Million
Q1 2024 May 06, 2024	BUY	$25.89 - $29.73 $100,686 - $115,619	3,889 Added 1.28%	308,638 $8.56 Million
Q4 2023 Feb 06, 2024	BUY	$26.13 - $33.94 $1.1 Million - $1.43 Million	42,083 Added 16.02%	304,749 $8.77 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $1.24 Million - $1.44 Million	38,492 Added 17.17%	262,666 $8.71 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $132,163 - $152,909	-3,659 Reduced 1.61%	224,174 $8.22 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $2.46 Million - $3.2 Million	62,398 Added 37.72%	227,833 $9.3 Million
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $2.85 Million - $3.72 Million	68,328 Added 70.36%	165,435 $8.48 Million
Q3 2022 Nov 08, 2022	BUY	$43.76 - $53.42 $209,304 - $255,507	4,783 Added 5.18%	97,107 $4.25 Million
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $104,692 - $124,132	2,250 Added 2.5%	92,324 $4.84 Million
Q1 2022 May 03, 2022	BUY	$45.75 - $56.69 $1.75 Million - $2.17 Million	38,192 Added 73.61%	90,074 $4.66 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $2.14 Million - $3.18 Million	51,882 New	51,882 $3.06 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metis Global Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Metis Global Partners, LLC with notifications on news.

Account

Metis Global Partners, LLC Pfizer Inc Transaction History